Abstract
Combination therapy for mycosis fungoides (MF) has the potential to be synergistic, improve therapeutic efficacy and reduce toxicities. We present a patient with MF who improved on combination therapy with bexarotene and narrowband ultraviolet B (NB‐UVB) therapy. The patient is an 81‐year‐old Caucasian male who initially presented with stage IB MF. After temporary improvement with NB‐UVB phototherapy, he progressed to develop plaques and tumors. Psoralen and ultraviolet A therapy was contraindicated because of ophthalmologic disease. Addition of bexarotene 300 mg daily led to rapid clinical improvement in combination with NB‐UVB. Interruption of NB‐UVB during a prolonged hospitalization led to a clinical flare of lesions, despite continued treatment with bexarotene. Reinitiating NB‐UVB was associated with clinical improvement. This report demonstrates that combination treatment with oral bexarotene and NB‐UVB therapy may represent a safe alternative for the treatment of plaque‐stage MF.

This publication has 7 references indexed in Scilit: